Stock Price
1,317.80
Daily Change
-23.30 -1.74%
Monthly
0.37%
Yearly
-10.76%
Q1 Forecast
1,315.62

Cipla reported INR15.2 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Dec/2025 11.20 14.92 19.43 Jan/23 2026
FY2026Q1 Sep/2025 16.72 15.33 16.12 Oct/29 2025
FY2026Q1 Jun/2025 16.06 14.87 14.57 Jul/25 2025
FY2025Q4 Mar/2025 15.10 12.29 11.62 May/12 2025
FY2025Q3 Dec/2024 19.43 14.13 13.07 Jan/28 2025




Eps Change Date
Arca Biopharma USD -0.5 0.08 Mar/2025
aTyr Pharma USD -0.26 0.05 Sep/2025
Bio Path USD -0.4 0.33 Mar/2025
Brainstorm Cell Therapeutics USD -0.45 0.06 Mar/2025
Capricor Therapeutics USD -0.53 0.37 Mar/2025
Cara Therapeutics USD -5.04 3.24 Dec/2024
Cipla INR 15.2 1.52 Dec/2025
Dr.Reddys Laboratories INR 14.52 2.98 Dec/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Immunic USD -0.24 0.03 Sep/2024
Infinity Pharmaceuticals USD -0.11 0.01 Jun/2023
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sun Pharmaceuticals INR 12.8 0.2 Dec/2025
TherapeuticsMD USD -0.09 0.02 Jun/2024
UPL INR 4.69 2.11 Dec/2025